Current Drug Targets
Title:Editorial: High Performance Computing in Drug Discovery
Volume: 17 Issue: 14
Author(s): Horacio Pérez-Sánchez, Sandra Gesing and Ivan Merelli
Affiliation:
Export Options
About this article
Cite this article as:
Pérez-Sánchez Horacio, Gesing Sandra and Merelli Ivan, Editorial: High Performance Computing in Drug Discovery, Current Drug Targets 2016; 17 (14) . https://dx.doi.org/10.2174/138945011714160930230542
DOI https://dx.doi.org/10.2174/138945011714160930230542 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers